Keratoconus in 2026: Epi-On Cross-Linking and Tissue-Addition Keratoplasty
About this Event
A practical evening review of what has changed in keratoconus management in the past 18 months — and what to do with it Monday morning.
In October 2025, the FDA approved the first incision-free, epithelium-on corneal cross-linking treatment (Epioxa, Glaukos). Corneal tissue-addition keratoplasty (CTAK) reached enough U.S. centers that patients are now asking about it. Most practicing optometrists have not yet received structured education on either.
This course closes that gap. Course content is independently developed, peer-reviewed by an unaffiliated cornea specialist, and balanced across all currently FDA-approved cross-linking options and the full alternatives panel (CAIRS, Intacs, topo-guided PRK, scleral lenses, DALK, PKP).
WHAT YOU WILL LEAVE ABLE TO DO
• Stage keratoconus using current tomography and biomechanical indices, and know when to refer.
• Compare candidacy and expected outcomes across epi-off cross-linking, epi-on cross-linking, and corneal tissue-addition keratoplasty.
• Apply updated co-management protocols, including how to distinguish sterile from microbial post-operative infiltrate.
AGENDA
5:30–6:00 PM Registration, light refreshments, networking
6:00–6:55 PM Hour 1 — Foundations, diagnosis, staging, cross-linking science
6:55–7:05 PM Break
7:05–7:55 PM Hour 2 — Epi-on cross-linking, CTAK, optometric co-management
7:55–8:00 PM Cases, audience polling, Q&A
8:00–8:30 PM Optional networking and exhibitor tabletop visit
CE CREDIT
This course has been submitted to the California State Board of Optometry for 2 hours of CE credit approval under §1536 (Ocular Disease category, TPA-eligible). Approval is pending at the time of registration. Upon Board approval, attendees will receive a Certificate of Completion bearing the assigned course approval number.
INSTRUCTOR
Rajesh Khanna, MD
• Board Certified, American Board of Ophthalmology (2006)
• Fellowship: Cornea and Refractive Surgery, University of Cincinnati
• Residency: SUNY Downstate Medical Center
• Voluntary Clinical Instructor, Jules Stein Eye Institute, UCLA
• Affiliated, Los Robles Health System, Thousand Oaks
• 25,000+ procedures performed
• Southern California Super Doctor, 2019–2024 (six consecutive years)
• Author: Rejuvenate Aging Eyes: The Miracle of PIE; SMILE Laser Vision Correction
VENUE AND PARKING
Courtyard by Marriott Thousand Oaks Ventura County1710 Newbury Road, Newbury Park, CA 91320(833) 320-5612
Complimentary on-site parking. Meeting room signage will direct attendees from the lobby.
REFRESHMENTS
Light refreshments (coffee, tea, water, light snacks) provided during the 5:30–6:00 PM registration window and the 6:55–7:05 PM break.
FINANCIAL DISCLOSURE
Dr. Khanna holds equity in Glaukos Corporation, manufacturer of Photrexa and Epioxa, both referenced in this course. This disclosure is read aloud at the start of the activity and stated on the opening slide. Course content was developed independently of all commercial interests and was peer-reviewed by an unaffiliated cornea specialist prior to delivery. No ineligible company has influenced course content. All FDA-approved cross-linking products and alternative refractive rehabilitation procedures are presented for balance.
REGISTRATION
$25 per attendee. Seating is limited to 60. Registration closes Thursday, July 23 at 5:00 PM.
OPEN TO
All California-licensed optometrists, optometric residents, and ophthalmology residents.
QUESTIONS
Email [email protected] or call (805) 230-2126.
Agenda
🕑: 05:30 PM - 06:00 PM
Registration, Light Refreshments, Networking
🕑: 06:00 PM - 06:55 PM
Hour 1 — Foundations, Diagnosis, Staging, Cross-Linking Science
🕑: 06:55 PM - 07:05 PM
Break
🕑: 07:05 PM - 07:55 PM
Hour 2 — Epi-on Cross-Linking, CTAK, Optometric Co-Management
🕑: 07:55 PM - 08:00 PM
Cases, Audience Polling, Q&A
🕑: 08:00 PM - 08:30 PM
Optional Networking and Exhibitor Tabletop Visit
Where is it happening?
Event Location & Nearby Stays:
USD 28.52
